NASDAQ:KNSA

Kiniksa Pharmaceuticals . Class A Stock Predictions

etoro logo Buy KNSA
*Your capital is at risk
$47.85
+0.93 (+1.98%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

KNSA Prediction Chart

KNSA Predictions History

Latest community submissions for KNSA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 16, 2025 $40.79 +41.63% $28.42 X 56.47% 1
AlexVel AlexVel Pro
Jun 14, 2023 $15.78 -1.38% $16.48 X 95.75% 0
Jun 14, 2023 $15.75 -1.57% $16.48 X 95.56% 0
Jun 14, 2023 $15.84 -0.98% $16.48 X 96.13% 0
JS JS Pro
Jun 14, 2023 $15.78 -1.38% $16.48 X 95.75% 0
JS JS Pro
May 30, 2023 $14.16 +0.64% $13.67 X 96.42% 0
May 30, 2023 $13.80 -1.92% $13.67 V 99.05% 2
May 30, 2023 $13.90 -1.20% $13.67 V 98.31% 1
Aug 8, 2022 Bullish $12.95 X 0
JS JS Pro
Mar 22, 2021 $20.03 +3.89% $19.28 X 96.11% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KNSA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINIKSA PHARMACEUTICALS LTD. CLASS A
Kiniksa Pharmaceuticals . Class A
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclo...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE